The University of Chicago Header Logo

Connection

Christopher Olopade to Disease-Free Survival

Back to Details
This is a "connection" page, showing publications Christopher Olopade has written about Disease-Free Survival.
Christopher Olopade
Connection Strength
0.050
Disease-Free Survival
  1. Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (ARETTA). JCO Glob Oncol. 2026 May; 12(5):e2500287.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.